Literature DB >> 26377253

Body mass index, physical activity, and risk of adult meningioma and glioma: A meta-analysis.

Tobias Niedermaier1, Gundula Behrens2, Daniela Schmid1, Inga Schlecht1, Beate Fischer1, Michael F Leitzmann1.   

Abstract

OBJECTIVE: Whether adiposity and lack of physical activity affect the risk for developing meningioma and glioma is poorly understood. Our objective was to characterize these associations in detail.
METHODS: We conducted a systematic review and meta-analysis of adiposity and physical activity in relation to meningioma and glioma using cohort and case-control studies published through February 2015. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
RESULTS: We identified 12 eligible studies of body mass index (BMI) and 6 studies of physical activity, comprising up to 2,982 meningioma cases and 3,057 glioma cases. Using normal weight as the reference group, overweight (summary relative risk [RR] = 1.21, 95% confidence interval [CI] = 1.01-1.43) and obesity (RR = 1.54, 95% CI = 1.32-1.79) were associated with increased risk of meningioma. In contrast, overweight (RR = 1.06, 95% CI = 0.94-1.20) and obesity (RR = 1.11, 95% CI = 0.98-1.27) were unrelated to glioma. Similarly, dose-response meta-analyses revealed a statistically significant positive association of BMI with meningioma, but not glioma. High vs low physical activity levels showed a modest inverse relation to meningioma (RR = 0.73, 95% CI = 0.61-0.88) and a weak inverse association with glioma (RR = 0.86, 95% CI = 0.76-0.97). Relations persisted when the data were restricted to prospective studies, except for the association between physical activity and glioma, which was rendered statistically nonsignificant (RR = 0.91, 95% CI = 0.77-1.07).
CONCLUSIONS: Adiposity is related to enhanced risk for meningioma but is unassociated with risk for glioma. Based on a limited body of evidence, physical activity is related to decreased risk of meningioma but shows little association with risk of glioma.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Year:  2015        PMID: 26377253     DOI: 10.1212/WNL.0000000000002020

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  42 in total

Review 1.  Genetic and molecular epidemiology of adult diffuse glioma.

Authors:  Annette M Molinaro; Jennie W Taylor; John K Wiencke; Margaret R Wrensch
Journal:  Nat Rev Neurol       Date:  2019-06-21       Impact factor: 42.937

2.  Brain cancer risk: the weight of obesity.

Authors:  Maurizio Bifulco; Roberta Ranieri; Elena Ciaglia
Journal:  J Neurooncol       Date:  2016-11-09       Impact factor: 4.130

3.  Cancers Due to Excess Weight, Low Physical Activity, and Unhealthy Diet.

Authors:  Gundula Behrens; Thomas Gredner; Christian Stock; Michael F Leitzmann; Hermann Brenner; Ute Mons
Journal:  Dtsch Arztebl Int       Date:  2018-09-03       Impact factor: 5.594

4.  Factors Associated With Meningioma Detected in a Population-Based Sample.

Authors:  Jane H Cerhan; Alissa M Butts; Jeremy A Syrjanen; Jeremiah A Aakre; Paul D Brown; Ronald C Petersen; Clifford R Jack; Rosebud O Roberts
Journal:  Mayo Clin Proc       Date:  2019-02       Impact factor: 7.616

5.  The association between obesity and self-reported current depression among adult cancer survivors residing in Brazil.

Authors:  Gisele Dias de Oliveira; S Cristina Oancea; Luciana B Nucci; Nancy Vogeltanz-Holm
Journal:  Int Health       Date:  2019-11-13       Impact factor: 2.473

6.  IDENTIFYING CANCER SPECIFIC METABOLIC SIGNATURES USING CONSTRAINT-BASED MODELS.

Authors:  A Schultz; S Mehta; C W Hu; F W Hoff; T M Horton; S M Kornblau; A A Qutub
Journal:  Pac Symp Biocomput       Date:  2017

7.  Body mass index as an independent prognostic factor in glioblastoma.

Authors:  Pedro Valente Aguiar; Bruno Carvalho; Rui Vaz; Paulo Linhares
Journal:  Cancer Causes Control       Date:  2021-01-15       Impact factor: 2.506

8.  Allergic conditions and risk of glioma and meningioma in the CERENAT case-control study.

Authors:  Camille Pouchieu; Chantal Raherison; Clément Piel; Lucile Migault; Camille Carles; Pascale Fabbro-Perray; Hugues Loiseau; Jean-Sébastien Guillamo; Pierre Lebailly; Isabelle Baldi
Journal:  J Neurooncol       Date:  2018-03-02       Impact factor: 4.130

9.  Body mass index, comorbidities, and hormonal factors in relation to meningioma in an ethnically diverse population: the Multiethnic Cohort.

Authors:  Ivo S Muskens; Anna H Wu; Jacqueline Porcel; Iona Cheng; Loïc Le Marchand; Joseph L Wiemels; Veronica Wendy Setiawan
Journal:  Neuro Oncol       Date:  2019-03-18       Impact factor: 12.300

10.  Body Fatness and Cancer--Viewpoint of the IARC Working Group.

Authors:  Béatrice Lauby-Secretan; Chiara Scoccianti; Dana Loomis; Yann Grosse; Franca Bianchini; Kurt Straif
Journal:  N Engl J Med       Date:  2016-08-25       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.